Genetic Alterations that Initiate Follicular Thyroid Carcinogenesis

引发滤泡性甲状腺癌的基因改变

基本信息

  • 批准号:
    8697754
  • 负责人:
  • 金额:
    $ 40.75万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2008
  • 资助国家:
    美国
  • 起止时间:
    2008-03-01 至
  • 项目状态:
    未结题

项目摘要

Project 2 takes a clinical and translational genetics approach to identify and characterize genes and their pathways that play a role In the initiation of differentiated thyroid cancer (DTC) for the purposes of the eariiest diagnosis via gene-enabled cancer risk assessment. We will utilize human Cowden syndrome (CS), and a mouse model of human Carney Complex (CNC), as our models epitomizing germline (inherited) predisposition as the first event in initiation in a heritable thyroid neoplasia disorder. CS is a difficult-to- recognize, under-diagnosed heritable disorder characterized by follicular thyroid adenomas (FA), DTC and breast cancer. We found that germline PTEN mutations cause finite subsets of CS and other clinical syndromes, which we collectively term PTEN hamartoma-tumor syndrome (PHTS). Germline PRKR1A mutations associate with CNC. In the first grant period, we have prospectively accrued >3,000 probands from community and academic medical centers who meet CS or CS-like (CSL) criteria and created a web- based PTEN risk calculator based on presence/absence of pathogenic PTEN mutations and clinical characteristics; and showed 32% lifetime risk of DTC in PHTS. We found functional germline variants in SDHB and SDHD, encoding 2 subunits of succinate dehydrogenase, resulting in destabilization of p53 via NQ01 and decreasing ATP levels associated with PTEN nuclear trapping, we developed mouse models of the spectrum of FTC, including FA (thyroid-specific Pten knock-out), locally invasive FTC (Prkaria KO), and metastatic FTC (Pten/Prkaria double KO); preliminary data Indicating downregulation of Sdhb and other Sdh subunits in the FTC models, we broadly hypothesize that Interactions of PTEN, SDHx and PRKR1A play a role in thyroid neoplasia initiation by modulating ROS and other mitochondria-associated energetics. We will (1) analyze SDHx and PRKARIA germline variants In modifying the risk and sub-histology of DTC and of other component cancers in PTEN mutation positive CS/CSL patients; (2) mitochondrial energetics-relevant in vitro functional assays to analyse the interaction of PTEN and SDHx; and (3) physiological validate our human in vivo and in vitro observations in murine models.
项目2采用临床和转化遗传学方法来识别和表征基因及其表达。 出于本研究的目的,在分化型甲状腺癌(DTC)的发生中发挥作用的途径 通过基因启动的癌症风险评估进行最早诊断。我们将利用人类考登综合征(CS), 和人类Carney复合体(CNC)的小鼠模型,作为我们的模型的缩影生殖系(遗传) 易感性作为遗传性甲状腺瘤形成疾病启动的第一个事件。CS是一个很难- 识别,诊断不足的遗传性疾病的特点是滤泡性甲状腺腺瘤(FA),DTC和 乳腺癌我们发现,生殖系PTEN突变导致CS和其他临床疾病的有限子集。 综合征,我们统称为PTEN错构瘤-肿瘤综合征(PHTS)。生殖系PRKR 1A 突变与CNC相关。在第一个补助期,我们预期累积了> 3,000名先证者 从社区和学术医疗中心谁符合CS或CS样(CSL)的标准,并创建了一个网络- 基于致病性PTEN突变的存在/不存在和临床 在PHTS中,DTC的终生风险为32%。我们发现了功能性生殖系变异, SDHB和SDHD,编码琥珀酸脱氢酶的2个亚基,导致p53的不稳定, NQ 01和与PTEN核捕获相关的ATP水平降低,我们开发了小鼠模型, FTC的谱,包括FA(甲状腺特异性Pten敲除)、局部侵袭性FTC(Prkaria KO)和 转移性FTC(Pten/Prkaria双KO);初步数据表明Sdhb和其他Sdh下调 在FTC模型中,我们广泛地假设PTEN,SDHx和PRKR 1A的相互作用起着重要的作用。 通过调节ROS和其他与甲状腺相关的能量学在甲状腺肿瘤形成中起作用。我们将 (1)分析SDHx和PRKARIA生殖系变异,以改变DTC的风险和亚组织学, PTEN突变阳性CS/CSL患者中的其他组分癌症;(2)线粒体能量相关 体外功能测定以分析PTEN和SDHx的相互作用;和(3)生理学验证我们的 在鼠模型中的人体内和体外观察。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Charis Eng其他文献

Charis Eng的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Charis Eng', 18)}}的其他基金

The 6th Annual International PTEN Symposium: From Patient-Centered Research to Clinical Care
第六届国际 PTEN 研讨会:从以患者为中心的研究到临床护理
  • 批准号:
    10683454
  • 财政年份:
    2023
  • 资助金额:
    $ 40.75万
  • 项目类别:
Modeling Autism and Comorbid Cancer Risk in Individuals with Germline PTEN Mutations
种系 PTEN 突变个体的自闭症和共病癌症风险建模
  • 批准号:
    10704496
  • 财政年份:
    2022
  • 资助金额:
    $ 40.75万
  • 项目类别:
Modeling Autism and Comorbid Cancer Risk in Individuals with Germline PTEN Mutations
种系 PTEN 突变个体的自闭症和共病癌症风险建模
  • 批准号:
    10358435
  • 财政年份:
    2022
  • 资助金额:
    $ 40.75万
  • 项目类别:
Natural history of individuals with autism spectrum disorder and germline PTEN mutations
患有自闭症谱系障碍和种系 PTEN 突变的个体的自然史
  • 批准号:
    10242080
  • 财政年份:
    2014
  • 资助金额:
    $ 40.75万
  • 项目类别:
Natural history of individuals with autism spectrum disorder and germline PTEN mutations
患有自闭症谱系障碍和种系 PTEN 突变的个体的自然史
  • 批准号:
    10701741
  • 财政年份:
    2014
  • 资助金额:
    $ 40.75万
  • 项目类别:
Deep Sequencing Instrumentation Upgrade - Illumina HiSeq2500
深度测序仪器升级 - Illumina HiSeq2500
  • 批准号:
    8640603
  • 财政年份:
    2014
  • 资助金额:
    $ 40.75万
  • 项目类别:
Metagenomic profiling of oral polymicrobial flora in head and neck cancers
头颈癌口腔多微生物菌群的宏基因组分析
  • 批准号:
    8142045
  • 财政年份:
    2010
  • 资助金额:
    $ 40.75万
  • 项目类别:
Next Generation Sequencer
下一代测序仪
  • 批准号:
    7791131
  • 财政年份:
    2010
  • 资助金额:
    $ 40.75万
  • 项目类别:
Genetic Alterations that Initiate Follicular Thyroid Carcinogenesis
引发滤泡性甲状腺癌的基因改变
  • 批准号:
    8505981
  • 财政年份:
    2008
  • 资助金额:
    $ 40.75万
  • 项目类别:
Genetic Alterations that Initiate Follicular Thyroid Carcinogenesis
引发滤泡性甲状腺癌的基因改变
  • 批准号:
    9041528
  • 财政年份:
    2008
  • 资助金额:
    $ 40.75万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 40.75万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 40.75万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 40.75万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 40.75万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 40.75万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 40.75万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 40.75万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 40.75万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 40.75万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 40.75万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了